Personalized Cannabidiol Delivery Systems
Legal Citation
Summary of the Inventive Concept
A next-generation self-emulsifying cannabidiol technology integrating wearable devices, machine learning, and novel surfactant blends to optimize bioavailability, pharmacokinetics, and personalized treatment of neurological disorders.
Background and Problem Solved
The original patent disclosed self-emulsifying cannabidiol formulations, but limitations existed in terms of personalized delivery, bioavailability, and pharmacokinetics. The new inventive concept addresses these limitations by introducing wearable devices, machine learning algorithms, and novel surfactant blends to optimize cannabidiol treatment.
Detailed Description of the Inventive Concept
The inventive concept comprises a self-emulsifying cannabidiol composition, a wearable device for monitoring a subject's physiological response, and machine learning algorithms to predict optimal dosing regimens. The composition may include novel surfactant blends optimized for enhanced gut-brain axis interaction and administered via nasal spray or transdermal patch. A device for real-time monitoring of cannabidiol pharmacokinetics provides personalized dosing recommendations based on the subject's real-time cannabidiol levels. The inventive concept enables personalized treatment of neurological disorders, such as epilepsy, multiple sclerosis, and Parkinson's disease, in combination with neurostimulation therapies.
Novelty and Inventive Step
The new claims introduce wearable devices, machine learning algorithms, and novel surfactant blends, which are not obvious from the original patent. The integration of these components enables personalized cannabidiol delivery, optimized bioavailability, and real-time pharmacokinetics monitoring, making the inventive concept novel and non-obvious.
Alternative Embodiments and Variations
Alternative embodiments may include variations in wearable device design, machine learning algorithm implementation, and novel surfactant blend compositions. Additionally, the inventive concept could be adapted for use in veterinary medicine or for treating other diseases, such as cancer or inflammatory disorders.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and biotechnology industries, particularly in the growing markets for personalized medicine and cannabidiol-based treatments. Target industries include pharmaceutical companies, biotech startups, and medical device manufacturers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/107 |
| A | A61 | A61K9/4808 |
| A | A61 | A61K9/4825 |
| A | A61 | A61K31/05 |
| A | A61 | A61K47/10 |
| A | A61 | A61K47/14 |
| A | A61 | A61K47/22 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation and drug delivery systems, specifically focused on cannabinoid compositions, with expertise in emulsion technologies, surfactant design, and personalized medical delivery systems
Person of Ordinary Skill (PHOSITA) Profile
A pharmaceutical scientist or biomedical engineer with advanced degrees in pharmaceutical sciences, expertise in drug formulation, knowledge of emulsion technologies, familiarity with cannabinoid delivery mechanisms, and understanding of machine learning applications in personalized medicine
Obviousness Rationale
A person having ordinary skill in the art would recognize that the PTD's integration of wearable monitoring technology and machine learning with self-emulsifying cannabidiol compositions represents a predictable extension of existing pharmaceutical personalization strategies. The core cannabidiol formulation remains substantially similar to the source patent, with the primary innovations being the addition of monitoring and adaptive dosing technologies. These technological additions would be considered obvious improvements within the standard progression of pharmaceutical delivery systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,678 |
|---|---|
| Title | Self-emulsifying cannabidiol formulations |
| Assignee(s) | Benuvia Operations, LLC |